Screening | Who needs it | How often |
---|
Alcohol misuse | All adults | At routine exams |
Blood pressure | All adults | Yearly checkup if your blood pressure is normal* Normal blood pressure is less than 120/80 mm Hg* If your blood pressure reading is higher than normal, follow the advice of your healthcare provider |
Breast cancer | All women in this age group should talk with their healthcare providers about breast self-awareness | At routine exams |
Cervical cancer | Women ages 21 and older | Women between ages 21 and 29 should have a Pap test every 3 years; women between the ages 30 and 65 should have a Pap test plus an HPV test every 5 years. |
Chlamydia | Sexually active women ages 24 and younger, and women at increased risk for infection | Every 3 years if at risk or if you have symptoms |
Depression | All women in this age group | At routine exams |
Type 2 diabetes | All women with no symptoms who are overweight or obese and have 1 or more additional risk factors for diabetes | At least every 3 years (annual testing if blood sugar has begun to rise) |
Type 2 diabetes or prediabetes | All women diagnosed with gestational diabetes | Lifelong testing every 3 years |
Type 2 diabetes | All women with prediabetes | Every year |
Gonorrhea | Sexually active women at increased risk for infection | At routine exams |
Hepatitis C | Anyone at increased risk for infection | At routine exams |
HIV | All women | At routine exams |
Obesity | All adults | At routine exams |
Syphilis | Women at increased risk for infection | At routine exams if at risk |
Tuberculosis | Anyone at increased risk for infection | Check with your healthcare provider |
Vision | Women in this age group1 | Every 5 to 10 years if not risk factors for eye disease |
Counseling | Who needs it | How often |
---|
Breast cancer, chemoprevention | Women at high risk | When risk is identified |
BRCA mutation testing for breast and ovarian cancer susceptibility | Women with increased risk | When risk is identified |
Diet and exercise | Women who are overweight or obese | When diagnosed and at routine exams |
Domestic violence | Women at the age in which they are able to have children | At routine exams |
Sexually transmitted infection prevention | Women who are sexually active | At routine exams |
Skin cancer | Prevention of skin cancer in fair-skinned adults through age 24 | At routine exams |
Tobacco use and tobacco-related disease | All adults | Every exam |
Immunizations*** | Who needs it | How often |
---|
Human papillomavirus (HPV) | All women in this age group up to age 26 | 3 doses The second dose should be given 1 to 2 months after the first dose, and the third dose should be given 6 months after the first dose |
Tetanus/diphtheria/pertussis (Td/Tdap) booster | All adults | Td: every 10 years Tdap: substitute a one-time dose of Tdap for a Td booster after age 18, then boost with Td every 10 years |
Chickenpox (varicella) | All adults in this age group who have no record of previous infection or vaccinations | 2 doses; the second dose should be given 4 to 8 weeks after the first dose |
Measles, mumps, rubella (MMR) vaccine | All adults in this age group who have no record of previous infection or vaccinations | 1 or 2 doses |
Flu vaccine (seasonal) | All adults | Yearly, when the vaccine becomes available in the community |
Haemophilus influenzae Type B (HIB) | Women at increased risk for infection – talk with your healthcare provider | 1 to 3 doses |
Hepatitis A vaccine | People at risk2 | 2 doses given at least 6 months apart |
Hepatitis B vaccine | People at risk3 | 3 doses; second dose should be given 1 month after the first dose; the third dose should be given at least 2 months after the second dose (and at least 4 months after the first dose) |
Meningococcal | People at risk4 | 1 or more doses |
Pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23) | People at risk5 | PCV13: 1 dose ages 19 to 65 (protects against 13 types of pneumococcal bacteria) PPSV23: 1 to 2 doses through age 64, or 1 dose at 65 or older (protects against 23 types of pneumococcal bacteria) |